GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Bentham Science Publishers Ltd.  (2)
  • Pharmacy  (2)
Material
Publisher
  • Bentham Science Publishers Ltd.  (2)
Language
Years
FID
  • Pharmacy  (2)
  • 1
    Online Resource
    Online Resource
    Bentham Science Publishers Ltd. ; 2023
    In:  Letters in Drug Design & Discovery Vol. 20, No. 6 ( 2023-06), p. 649-661
    In: Letters in Drug Design & Discovery, Bentham Science Publishers Ltd., Vol. 20, No. 6 ( 2023-06), p. 649-661
    Abstract: In recent years, Chinese herbal medicine has been gradually emerging as a suitable treatment option for breast cancer. However, the mechanism underlying its effects remains to be elucidated. Objective: The drug targets and Flos Daturae targets were intersected to obtain 86 component-disease intersection genes. Methods: The String database and Cytoscape3.8.0 were employed, and finally, AKT1, MYC, EGFR, MAPK14 PTGS2, and VEGFA were obtained as the six core genes. Results: According to the Gene Expression Profiling Interactive Analysis (GEPIA), six core gene correlation analysis figures were constructed. The GO enrichment analysis and the KEGG pathway enrichment analysis were conducted using the R package. Finally, molecular docking between the core genes and the main active components was performed for verification. Conclusion: The results indicated that Flos Daturae has multiple components and multiple targets that regulate the body functions, through which it plays a role in the treatment of breast cancer. In addition, it was inferred that polygenic regulation is better than the single-gene approach in breast cancer treatment.
    Type of Medium: Online Resource
    ISSN: 1570-1808
    Language: English
    Publisher: Bentham Science Publishers Ltd.
    Publication Date: 2023
    SSG: 15,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    Bentham Science Publishers Ltd. ; 2022
    In:  Anti-Cancer Agents in Medicinal Chemistry Vol. 22, No. 8 ( 2022-05), p. 1440-1457
    In: Anti-Cancer Agents in Medicinal Chemistry, Bentham Science Publishers Ltd., Vol. 22, No. 8 ( 2022-05), p. 1440-1457
    Abstract: Gastric cancer is a global cancer with a high mortality rate. A growing number of studies have found the abnormal expression of lncRNA (long noncoding RNA) in many tumors, which plays a role in promoting or inhibiting cancer. Similarly, lncRNA abnormal expression plays an essential biological function in gastric cancer. This article focuses on lncRNA involvement in the development of gastric cancer in terms of cell cycle disorder, apoptosis inhibition, metabolic remodeling, promotion of tumor inflammation, immune escape, induction of angiogenesis, and Epithelial Mesenchymal Transition (EMT). The involvement of lncRNA in the development of gastric cancer is related to drug resistance, such as cisplatin and multi-drug resistance. It can also be used as a potential marker for the diagnosis and prognosis of gastric cancer and a target for the treatment. With an in-depth understanding of the mechanism of lncRNA in gastric cancer, new ideas for personalized treatment of gastric cancer are expected.
    Type of Medium: Online Resource
    ISSN: 1871-5206
    Language: English
    Publisher: Bentham Science Publishers Ltd.
    Publication Date: 2022
    SSG: 15,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...